{"id":44330,"date":"2022-05-25T14:01:24","date_gmt":"2022-05-25T12:01:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/"},"modified":"2022-05-25T14:01:24","modified_gmt":"2022-05-25T12:01:24","slug":"imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/","title":{"rendered":"Imperative Care Announces 10,000 Patients Treated With Its Innovative Stroke Technologies"},"content":{"rendered":"
\n

\nCompany Reaches Milestone During Stroke Awareness Month, Serving as a Reminder to Learn the Signs of Stroke<\/i><\/b>\n<\/p>\n

CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc<\/a>. today announced that 10,000 patients have been treated in the U.S. with its technologies for stroke since 2020. The company\u2019s current portfolio includes the Zoom Stroke Solution\u2122 and TracStar\u00ae<\/sup> LDP technologies for ischemic and hemorrhagic stroke, which received FDA 510(k) clearance in 2019. With a physician-driven approach to innovation, the company is working to advance every aspect of the stroke procedure \u2013 from access through treatment \u2013 to empower clinicians and their staff with the right tools to continuously improve patient outcomes.\n<\/p>\n

<\/a><\/p>\n

\n\u201cThis is a very proud moment for us at Imperative Care, knowing that our technologies have made a very real impact on the lives of so many patients and their families,\u201d said Daniel Davis, COO of Imperative Care. \u201cWe are grateful for the physicians who have put their trust in us to deliver life-changing care to their patients.\u201d\n<\/p>\n

\n\u201cEvery day, the technologies that we develop at Imperative Care directly impact human lives,\u201d said Fred Khosravi, CEO of Imperative Care. \u201cOur focus is on the needs of the patient, and they come first in everything we do. This number is representative of that mission and the collective work of our team and physicians who are guided by the same North Star of patient care.\u201d\n<\/p>\n

\nStroke remains a largely unaddressed problem that affects over 800,000 Americans each year and 15 million people worldwide.1<\/sup> The number of deaths due to stroke continues to rise,2<\/sup> and a study published in The New England Journal of Medicine estimates that the global risk of stroke from the age of 25 years onward is approximately 25% among both men and women.3<\/sup> Treatment options have significantly improved over the last decade, but the need for improved effectiveness and efficiency remains.\n<\/p>\n

\n\u201cThe stroke treatment journey begins with recognition of a stroke, which is why it\u2019s so critical to know the warning signs,\u201d said Omar Tanweer, M.D., director of Cerebrovascular Neurosurgery and assistant professor at the Baylor College of Medicine in Houston. \u201cIn addition to increased public awareness, the advent of novel and promising technologies plays a key role in improving patient outcomes. The Zoom Stroke Solution has made a real difference in my practice, giving patients the best chance for optimal recovery.\u201d\n<\/p>\n

\nMay is Stroke Awareness Month, serving as an important reminder to learn the symptoms of stroke to help ensure timely treatment \u2013 a critical factor in stroke treatment. Visit the American Stroke Association\u2019s website<\/a> for more information and learn how to act F.A.S.T. when it comes to stroke.\n<\/p>\n

\nAbout the Zoom Stroke Solution<\/b>\n<\/p>\n

\nThe Zoom Stroke Solution is the complete stroke system from access through reperfusion for fast and effective clot removal for patients with acute ischemic stroke. The system includes the Zoom 88 Large Distal Platform for neurovascular access, four vessel-matched Zoom Aspiration Catheters, the Zoom Pump, the Zoom POD and other accessories. All Zoom catheters are designed with the TRX\u2122 Tip which provides 15% greater clot engagement area at the tip of the catheter and are designed to enable smooth tracking through challenging vasculature. For complete product information, including indications, contraindications, warnings, precautions and adverse events visit: http:\/\/bit.ly\/2Vx0Qcf<\/a>\n<\/p>\n

\nAbout Imperative Care, Inc.<\/b>\n<\/p>\n

\nImperative Care is a medical technology company focused on developing the next generation of innovative solutions to address the vast and urgent needs in stroke. The company has two 510(k) cleared product platforms, as well as an expansive stroke technology development pipeline. In addition, Imperative Care\u2019s wholly owned subsidiary Truvic is developing solutions for the treatment of peripheral vascular disease. Imperative Care and Truvic are based in Campbell, Calif. https:\/\/imperativecare.com<\/a>\n<\/p>\n

\n1. Mozzafarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al., on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association. Circulation2016;133(4):e38\u2013360.
\n
2. National Center for Health Statistics Mortality Data Report for 2017
\n
3. The GBD 2016 Lifetime Risk of Stroke Collaborators, Global, Regional and Country-Specific Lifetime Risks of Stroke, 1990 and 2016. N Engl J Med 2018; 379:2429-2437 DOI: 10.1056\/NEJMoa1804492\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b>
Matt Garrett, CFO
\n
Imperative Care, Inc.
\n
408-476-1672
\n
mgarrett@imperativecare.com<\/a>\n<\/p>\n

\nMedia Contact:<\/b>
Lara Lingenbrink
\n
Imperative Care, Inc.
\n
858-525-1414
\n
llingenbrink@imperativecare.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Company Reaches Milestone During Stroke Awareness Month, Serving as a Reminder to Learn the Signs of Stroke CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that 10,000 patients have been treated in the U.S. with its technologies for stroke since 2020. The company\u2019s current portfolio includes the Zoom Stroke Solution\u2122 and TracStar\u00ae LDP technologies for ischemic … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44330","6":"format-standard","7":"category-industry"},"yoast_head":"\nImperative Care Announces 10,000 Patients Treated With Its Innovative Stroke Technologies - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Imperative Care Announces 10,000 Patients Treated With Its Innovative Stroke Technologies - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Company Reaches Milestone During Stroke Awareness Month, Serving as a Reminder to Learn the Signs of Stroke CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that 10,000 patients have been treated in the U.S. with its technologies for stroke since 2020. The company\u2019s current portfolio includes the Zoom Stroke Solution\u2122 and TracStar\u00ae LDP technologies for ischemic ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-25T12:01:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220525005299\/en\/1466699\/21\/Updated_Imperative_Logo_-_Dark_Gray_Writing.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Imperative Care Announces 10,000 Patients Treated With Its Innovative Stroke Technologies\",\"datePublished\":\"2022-05-25T12:01:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\\\/\"},\"wordCount\":727,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220525005299\\\/en\\\/1466699\\\/21\\\/Updated_Imperative_Logo_-_Dark_Gray_Writing.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\\\/\",\"name\":\"Imperative Care Announces 10,000 Patients Treated With Its Innovative Stroke Technologies - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220525005299\\\/en\\\/1466699\\\/21\\\/Updated_Imperative_Logo_-_Dark_Gray_Writing.jpg\",\"datePublished\":\"2022-05-25T12:01:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220525005299\\\/en\\\/1466699\\\/21\\\/Updated_Imperative_Logo_-_Dark_Gray_Writing.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220525005299\\\/en\\\/1466699\\\/21\\\/Updated_Imperative_Logo_-_Dark_Gray_Writing.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Imperative Care Announces 10,000 Patients Treated With Its Innovative Stroke Technologies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Imperative Care Announces 10,000 Patients Treated With Its Innovative Stroke Technologies - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/","og_locale":"en_US","og_type":"article","og_title":"Imperative Care Announces 10,000 Patients Treated With Its Innovative Stroke Technologies - Pharma Trend","og_description":"Company Reaches Milestone During Stroke Awareness Month, Serving as a Reminder to Learn the Signs of Stroke CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that 10,000 patients have been treated in the U.S. with its technologies for stroke since 2020. The company\u2019s current portfolio includes the Zoom Stroke Solution\u2122 and TracStar\u00ae LDP technologies for ischemic ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-25T12:01:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220525005299\/en\/1466699\/21\/Updated_Imperative_Logo_-_Dark_Gray_Writing.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Imperative Care Announces 10,000 Patients Treated With Its Innovative Stroke Technologies","datePublished":"2022-05-25T12:01:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/"},"wordCount":727,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220525005299\/en\/1466699\/21\/Updated_Imperative_Logo_-_Dark_Gray_Writing.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/","url":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/","name":"Imperative Care Announces 10,000 Patients Treated With Its Innovative Stroke Technologies - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220525005299\/en\/1466699\/21\/Updated_Imperative_Logo_-_Dark_Gray_Writing.jpg","datePublished":"2022-05-25T12:01:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220525005299\/en\/1466699\/21\/Updated_Imperative_Logo_-_Dark_Gray_Writing.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220525005299\/en\/1466699\/21\/Updated_Imperative_Logo_-_Dark_Gray_Writing.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-10000-patients-treated-with-its-innovative-stroke-technologies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Imperative Care Announces 10,000 Patients Treated With Its Innovative Stroke Technologies"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44330"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44330\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44330"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44330"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}